Furthermore, we demonstrated that reduced dopamine release in PD-simBOs could be rescued by treatment with PFE-360 (Figure 7I), implying functional improvement of dopaminergic neurons by the LRRK2 inhibitor. The gene discussed is LRRK2; the disease is Parkinson disease.